Back

dr. J.E. (Joop) Arends

Associate Professor - medical

  • Internal Medicine

Research Programs

Research Output (109)

Low Sensitivity of the Fracture Risk Assessment Tool in Young HIV-Infected Patients: Time to Revise Our Screening Strategy

van Welzen Berend J, Yesilay Sultan, Arends Joop E, Hoepelman Andy I M, Mudrikova Tania 15 dec 2019, In: Journal of Acquired Immune Deficiency Syndromes. 82 , p. 439-442 4 p.

Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV

van Zoest Rosan A., Law Matthew, Sabin Caroline A., Vaartjes Ilonca, Van der Valk Marc, Arends Joop E., Prins J. M., van Vugt H. J. M., Peters E. J. G., Laan L. M., Ammerlaan H. S. M., Groot M., Brouwer A. E., de Groot J., Koopmans M. P. G., Pas S. D., Heikens E., Lammers A. J. J., Bor P. C. J., de Boer M. G. J., Smit J. V., Smit E., Kampschreur L. M., Dijkstra K., Weel J., Stuart J. W. T. Cohen, Jansen R., Blok W. L., de Haan M., van Lelyveld S. F. L., Jansen R., van Wijk M., Bakker M., Hoepelman A. I. M., Barth R. E., Bruns A. H. W., Ellerbroek P. M., Mudrikova T., Oosterheert J. J., Schadd E. M., Wassenberg M. W. M., van Zoelen M. A. D., Aarsman K., van Berkel M., Schuurman R., Wensing A. M. J., de Jong A., van der Meer R., Paling F., van der Vliet S., 15 aug 2019, In: Journal of Acquired Immune Deficiency Syndromes. 81 , p. 562-571 10 p.

Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project:a mixed method study

Kracht Patricia A M, de Gee Elisabeth A, van der Poel Agnes, Verhagen Marc A M T, Hoepelman Andy I M, Croes Esther A, Arends Joop E 15 jul 2019, In: Harm Reduction Journal [E]. 16

Retrieval of chronic hepatitis B patients in the Utrecht region in the Netherlands

Dimmendaal M., Kracht P. A. M., Dijkstra S., Arends J. E., Woonink F., Hoepelman A. I. M., Boland G. J., Vlaminckx B. J. M., Stadhouders P. H. G. M., Thijsen S. F. T., Verhagen M. A. M. T., Friederich P. W., Weersink A. J. L. jul 2019, In: Netherlands Journal of Medicine. 77 , p. 199-209

Switching tenofovir disoproxil fumarate to tenofovir alafenamide results in a significant decline in parathyroid hormone levels:uncovering the mechanism of tenofovir disoproxil fumarate-related bone loss?

Van Welzen Berend J, Thielen Matheus A J, Mudrikova Tania, Arends Joop E, Hoepelman Andy I M 22 apr 2019, In: AIDS. 33 , p. 1531-1534 4 p.

Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM

Newsum Astrid M., Kooij Katherine W., Boyd Anders, Smit Colette, van Eden H., Steba G. S., Prins J. M., Peters E. J. G., Laan L. M., Brouwer A. E., Adams A., de Groot J., Koopmans M. P. G., Heikens E., Lammers A. J. J., Bor P. C. J., de Boer M. G. J., Smit J., V, Smit E., Kampschreur L. M., Stuart J. W. T. Cohen, Hoogewerf M., Sinnige J. C., Blok W. L., Albers M., de Haan M., van Lelyveld S. F. L., Jansen R., van Wijk M., Bakker M., Hoepelman A. I. M., Arends J. E., Barth R. E., Bruns A. H. W., Ellerbroek P. M., Mudrikova T., Oosterheert J. J., de Regt M. J. A., Schadd E. M., Wassenberg M. W. M., van Zoelen M. A. D., Aarsman K., van Berkel M., Schuurman R., Wensing A. M. J., de Jong A., van der Meer R., Paling E., van der Vliet S., Arends J. E., 1 apr 2019, In: AIDS. 33 , p. 833-844 12 p.

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients:The Next Big Thing?

van Welzen Berend J, Mudrikova Tania, El Idrissi Ayman, Hoepelman Andy I M, Arends Joop E 3 jan 2019, In: Infectious Diseases and Therapy. 8 , p. 33-50 18 p.

HIV, HCV and HBV:A Review of Parallels and Differences

Leoni Maria C., Ustianowski Andrew, Farooq Hamzah, Arends Joop E. 1 dec 2018, In: Infectious Diseases and Therapy. 7 , p. 407-419 13 p.

Objective and Subjective Improvement of Cognition After Discontinuing Efavirenz in Asymptomatic Patients:A Randomized Controlled Trial

Hakkers C S, Arends J E, van den Berk G E, Ensing M H M, Hooijenga I, Vink M, van Zandvoort M J E, Hoepelman A I M 24 sep 2018, In: Journal of Acquired Immune Deficiency Syndromes. 80 , p. E14-E22

The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes:A Dutch Prospective Cohort Study

Kracht Patricia A.M., Lieveld Faydra I., Amelung Linde M., Verstraete Carina J.R., Mauser-Bunschoten Eveline P., de Bruijne Joep, Siersema Peter D., Hoepelman Andy I.M., Arends Joop E., van Erpecum Karel J. 1 sep 2018, In: Infectious Diseases and Therapy. 7 , p. 373-385 13 p.

All Research Output (109)